Eric Ostertag, Chief Executive Officer at Poseida Therapeutics, Inc. (PSTX), sold 226,900 shares at $9.63 ($2.2M) on 2021-04-05, disclosed to the SEC on 2021-04-05.
Open-market sale of $2.2M PSTX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.55 | 27,347 | $261K | 12.0% |
| 2 | $9.55 | 27,347 | $261K | 12.0% |
| 3 | $9.55 | 29,834 | $285K | 13.1% |
| 4 | $9.55 | 29,834 | $285K | 13.1% |
| 5 | $9.63 | 28,549 | $275K | 12.6% |
| 6 | $9.63 | 26,170 |
| $252K |
| 11.6% |
| 7 | $9.63 | 28,549 | $275K | 12.6% |
| 8 | $9.63 | 26,170 | $252K | 11.6% |
| 9 | $10.32 | 1,617 | $17K | 0.8% |
| 10 | $10.32 | 1,483 | $15K | 0.7% |
| Total | $9.60 avg | 226,900 | $2.2M | 100% |
| Filing → |
| PSTX | SELL | 2021-11-10 | $268K | — | Filing → |
| PSTX | SELL | 2021-10-05 | $208K | — | Filing → |
| PSTX | SELL | 2021-09-22 | $160K | — | Filing → |